Autotaxin–lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling

Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice

(2022) Ela Karshovska et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation – implications in atherosclerosis

(2021) Josiane Fernandes da Silva et al.   CLINICAL SCIENCE

An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases

(2019) Shi-Hui Law et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting the Autotaxin – Lysophosphatidic Acid Receptor Axis in Cardiovascular Diseases

(2019) Yang Zhao et al.   BIOCHEMICAL PHARMACOLOGY

LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling

(2019) Divij Mathew et al.   Frontiers in Immunology

Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis

(2018) Silvia Aldi et al.   Molecular Therapy-Methods & Clinical Development

The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism

(2018) Liang Bao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

LPA1 receptor–mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction

(2017) Péter Tibor Dancs et al.   FASEB JOURNAL

Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61

(2016) Feng Hao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Arguing the Case for the Autotaxin–Lysophosphatidic Acid–Lipid Phosphate Phosphatase 3-Signaling Nexus in the Development and Complications of Atherosclerosis

(2014) Susan S. Smyth et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Oleoyl-Lysophosphatidylcholine Limits Endothelial Nitric Oxide Bioavailability by Induction of Reactive Oxygen Species

(2014) Andrijana Kozina et al.   PLoS One

Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase

(2013) Éva Ruisanchez et al.   FASEB JOURNAL

Acyl Chain-Dependent Effect of Lysophosphatidylcholine on Endothelium-Dependent Vasorelaxation

(2013) Shailaja P. Rao et al.   PLoS One

Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction

(2012) Jian Ye et al.   BMC BIOINFORMATICS

Targeted Deletion of LPA5Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain

(2012) Mu-En Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Primer3—new capabilities and interfaces

(2012) Andreas Untergasser et al.   NUCLEIC ACIDS RESEARCH

Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells

(2011) Zachary Fulkerson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Insights into autotaxin: how to produce and present a lipid mediator

(2011) Wouter H. Moolenaar et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Endothelial dysfunction and vascular disease

(2009) P. M. Vanhoutte et al.   Acta Physiologica

Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR

(2009) Yunhui Cheng et al.   CELLULAR SIGNALLING

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

The effect of tempol on endothelium-dependent vasodilatation and blood pressure

(2009) Ulf Simonsen et al.   PHARMACOLOGY & THERAPEUTICS

Expression patterns of the lysophospholipid receptor genes during mouse early development

(2008) Hideyo Ohuchi et al.   DEVELOPMENTAL DYNAMICS

Lysophosphatidic acid-induced platelet shape change revealed through LPA1–5receptor-selective probes and albumin

(2008) A. L. Khandoga et al.   PLATELETS